Diahn-Warng Perng Steve
Overview
Explore the profile of Diahn-Warng Perng Steve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porsbjerg C, Townend J, Bergeron C, Christoff G, Katsoulotos G, Larenas-Linnemann D, et al.
Front Immunol
. 2024 May;
15:1361891.
PMID: 38711495
Background: To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials. Aim:...
2.
Lee T, Price D, Yadav C, Roy R, Lim L, Wang E, et al.
Chest
. 2024 Feb;
166(1):28-38.
PMID: 38395297
Background: Exacerbation frequency strongly influences treatment choices in patients with severe asthma. Research Question: What is the extent of the variability of exacerbation rate across countries and its implications in...
3.
Chen W, Tran T, Sadatsafavi M, Murray R, Boon Wong N, Ali N, et al.
J Allergy Clin Immunol Pract
. 2024 Feb;
12(2):536-539.
PMID: 38336403
No abstract available.
4.
Perez-de-Llano L, Scelo G, Canonica G, Chen W, Henley W, Larenas-Linnemann D, et al.
Ann Allergy Asthma Immunol
. 2023 Dec;
132(5):610-622.e7.
PMID: 38151100
Background: There is little agreement on clinically useful criteria for identifying real-world responders to biologic treatments for asthma. Objective: To investigate the impact of pre-biologic impairment on meeting domain-specific biologic...
5.
Scelo G, Torres-Duque C, Maspero J, Tran T, Murray R, Martin N, et al.
Ann Allergy Asthma Immunol
. 2023 Aug;
132(1):42-53.
PMID: 37640263
Background: Investigation for the presence of asthma comorbidities is recommended by the Global Initiative for Asthma because their presence can complicate asthma management. Objective: To understand the prevalence and pattern...
6.
Chen W, Tran T, Sadatsafavi M, Murray R, Boon Wong N, Ali N, et al.
J Allergy Clin Immunol Pract
. 2023 Jun;
11(9):2732-2747.
PMID: 37301430
Background: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. Objective: To examine the...
7.
Pfeffer P, Ali N, Murray R, Ulrik C, Tran T, Maspero J, et al.
Allergy
. 2023 Mar;
78(7):1934-1948.
PMID: 36929509
Background: Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of biologic. Our aim was to describe the profile of...